| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
In the news
William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his first penned article, Dr. Morice reflects on the diagnostic landscape in the post-pandemic environment and predicts trends that could influence the market in 2024.
Dr. Morice expects at-home testing to play a bigger role in diagnostic care this year, and for artificial intelligence (AI) to automate and transform labs in a more focused way. He also anticipates modern technology to further improve industry efficiencies and profitability.
“Of course, with all this opportunity comes responsibility,” says Dr. Morice. “AI can help provide more insights into patients and their health, but it must be done in a way that protects patients and their privacy. AI must be carefully managed to make sure it doesn’t skew or bias data, which can make care less equitable and accessible.”
